BioAgilytix Acquires Cambridge Biomedical

BioAgilytix Acquires Cambridge Biomedical

Posted
Contract Pharma covers BioAgilytix’s recent acquisition of Cambridge Biomedical, a CRO specializing in large molecule bioanalysis based in the biotech hub of Boston, MA.

Cell-Based Assays

Learn how BioAgilytix provides the specialized large molecule insight and proven GLP / GMP knowledge needed to support a full range of cell-based assay (CBA) requirements.

Pharmacokinetics & Pharmacodynamics (PK/PD)

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Tell Us About Your Project

What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.

SPEAK TO A SCIENTIST

Featured Expert

Cell-Based Assays

Learn how BioAgilytix provides the specialized large molecule insight and proven GLP / GMP knowledge needed to support a full range of cell-based assay (CBA) requirements.

Pharmacokinetics & Pharmacodynamics (PK/PD)

See how our PK expertise complements our immunogenicity services by evaluating absorption, distribution, metabolism and excretion characteristics of a product.

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Tell Us About Your Project

What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.

SPEAK TO A SCIENTIST
Share This

USA Headquarters
2300 Englert Dr
Durham, NC, 27713
919-381-6097
 
European Headquarters
Lademannbogen 10
22339 Hamburg Germany
+49 40 526779 0
 
Boston Laboratory
1320 Soldiers Field Road
Boston, MA, 02135
617-456-0700
[email protected]
 
[email protected]

Services

Platforms

Copyright © 2021 BioAgilytix Labs. All rights reserved.